Related Experiment Video
Updated: Aug 13, 2026

08:47
Endoscopic Cholesteatoma Surgery
Published on: January 19, 2022
A Wait and Scan Protocol for Asymptomatic Postsurgical Cholesteatoma Recurrence: A Novel Management Strategy
David Kiderman1,2, Daniel Goldstein1,3, Meital Adi1,3
1Department of Otolaryngology, Head and Neck Surgery, Kaplan Medical Center, Rehovot, Israel.
Summary
Active MRI surveillance is a safe alternative to immediate surgery for small, asymptomatic postoperative cholesteatoma recurrence. This imaging-guided approach allows patients to avoid re-exploration while monitoring lesion size and symptoms.
Area of Science:
- Otolaryngology
- Diagnostic Imaging
- Surgical Oncology
Background:
- Postoperative cholesteatoma recurrence requires vigilant monitoring.
- Immediate surgical re-exploration carries risks and may not always be necessary for small, asymptomatic recurrences.
- Non-echo-planar diffusion-weighted MRI is a key tool for detecting cholesteatoma recurrence.
Purpose of the Study:
- To assess the feasibility and safety of active MRI surveillance for managing small, asymptomatic postoperative cholesteatoma recurrence.
- To determine if MRI surveillance can serve as a viable alternative to immediate surgical re-exploration.
- To evaluate the outcomes of active surveillance, including surgery-free survival and lesion growth rate.
Main Methods:
- Prospective, single-arm pilot study conducted at a secondary referral otology center.
- Included patients with ≤5 mm asymptomatic postoperative cholesteatoma recurrence on MRI, without critical structure proximity.
- Employed structured active surveillance with serial non-echo-planar diffusion-weighted MRI scans at 12-18 month intervals.
Main Results:
- Thirteen patients were followed for a mean of 43 months; 77% remained surgery-free.
- The mean lesion growth rate was 0.32 mm/year, with 23% showing spontaneous regression.
- Kaplan-Meier analysis showed 100% surgery-free survival at 24 months and 91% at 36 months.
Conclusions:
- Active MRI surveillance is a feasible and safe strategy for selected patients with small, asymptomatic postoperative cholesteatoma recurrence.
- This approach can defer the need for surgical re-exploration.
- Further research into imaging-guided surveillance for MRI-detected recurrence is warranted.

